Chronic Plaque Psoriasis Clinical Trial
The expertise in the characterization of transcriptomics profile in lesional psoriatic skin and on the availability of innovative therapy for these patients.The investigators propose to follow the modification of the skin transcriptomics profile in psoriatic patients during successful Adalimumab biotherapy. Skin transcriptomics profiles of normal skin, psoriatic non lesional skin, and psoriatic lesional skin before and after biotherapy will be compared. The investigators will focus on the modification of the cytokine "signature" in these skin lesions and of some markers of keratinocyte inflammation. The modification of the transcriptomics profile induced by the biotherapy will be correlated to the clinical response Psoriasis Area and Severity Index.
n/a
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03598790 -
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
|
Phase 3 | |
| Completed |
NCT00799877 -
Chronic Plaque Psoriasis (Ps) Registry
|
||
| Completed |
NCT02581345 -
Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
|
Phase 3 | |
| Withdrawn |
NCT01200264 -
Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy
|
Phase 2 | |
| Terminated |
NCT00972543 -
Raptiva in Palm and Sole Psoriasis
|
Phase 4 | |
| Not yet recruiting |
NCT00707070 -
Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis
|
Phase 4 | |
| Completed |
NCT00539929 -
Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis
|
Phase 2 | |
| Completed |
NCT02852967 -
A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
|
Phase 2 | |
| Completed |
NCT00770965 -
Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis
|
Phase 2 | |
| Active, not recruiting |
NCT06011733 -
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
|
Phase 3 | |
| Completed |
NCT00245765 -
Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy
|
Phase 2 | |
| Completed |
NCT00673556 -
A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate
|
Phase 3 | |
| Terminated |
NCT00844363 -
Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris
|
N/A | |
| Completed |
NCT00574249 -
Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
|
Phase 3 | |
| Completed |
NCT00512187 -
Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial
|
Phase 4 | |
| Completed |
NCT02570750 -
The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis
|
||
| Completed |
NCT00438360 -
Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
|
Phase 3 | |
| Active, not recruiting |
NCT03897075 -
Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis
|
Phase 3 | |
| Completed |
NCT01358578 -
Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
|
Phase 3 | |
| Completed |
NCT03536884 -
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
|
Phase 3 |